FIELD: medicine, pharmacology, pharmacy. SUBSTANCE: invention relates to using richlocaine as an anticonvulsive agent that exceeds standard preparations by activity being without allergic responses. EFFECT: valuable medicinal property of agent. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| RICHLOCAINE - DERMATOPROTECTIING PHARMACOLOGICAL AGENT | 1998 |
|
RU2261710C2 |
| ANESTHETIC COMPOSITION WITH PROLONGED EFFECT | 1999 |
|
RU2180557C2 |
| METHOD OF SYNTHESIS OF α-ISOMER OF 2,5-DIMETHYL-4-HYDROXYPIPERIDINE AS SEMIPRODUCT IN PRODUCTION OF TOPICAL ANESTHETIC RICHLOCAINE | 1998 |
|
RU2148577C1 |
| HALOGEN-SUBSTITUTED DERIVATIVES OF BENZOILPHENOBARBITAL EXHIBITING ANTISPASMODIC ACTIVITY | 1976 |
|
SU609286A1 |
| 8-METHYL-8-PHENYL-3-OXOTHIAZOLIDINO-[3,2-A]-PIPERAZINE OR ITS HYDROCHLORIDE SHOWING TRANQUILIZING ACTION | 1991 |
|
SU1829361A1 |
| 11-(4-TERT-BUTYLBENZYL)-2,3,4,5-TETRAHYDRO[1,3]DYAZEPINO[1,2-A]BENZIMIDAZOLE HYDROBROMIDE WITH ANXIOLYTIC AND ANTICONVULSANT ACTIVITY | 2017 |
|
RU2662242C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTICONVULSANT ACTIVITY FOR PARENTERAL INTRODUCTION | 2011 |
|
RU2463052C1 |
| 4-(3,4-DIBROMOTHIOPHENE CARBONYL)-2,6,8,12-TETRAACETYL-2,4,6,8,10,12-HEXAAZATETRACYCLO[5,5,0,0,0]DODECANE USED AS AN ANTICONVULSANT | 2018 |
|
RU2684107C1 |
| DERIVATIVE OF PYRROLIDINE ACETAMIDE OR ITS COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | 2000 |
|
RU2261093C2 |
| HYDRAZIDES OF DIARYLGLYCOLIC ACID DISPLAYING ANTICONVULSION ACTIVITY | 0 |
|
SU1089925A1 |
